PIK3CA and breast cancer: Of the 218 BC cases tested at the local hospital, 89 patients had PIK3CA mutations (Fig. 1D), accounting for 40.83% (39.33% for exon 9 mutation, 52.81% for exon 20 mutation, 7.86% for other types of mutations).